Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Enhancer of zeste 2 polycomb repressive complex 2 subunit polymorphisms in melanoma skin cancer risk.

Experimental dermatology - 1 Oct 2020

Belpinati Francesca, Malerba Giovanni, Dal Toè Melissa, Ceccuzzi Laura, Rodolfo Monica, Poli Albino, Turco Alberto, Vergani Elisabetta, Sangalli Antonella, Gomez-Lira Macarena

Abstract excerpt

Melanoma is the most deadly skin cancer, and its incidence is growing. EZH2, a member of the Polycomb Group (PcGs) proteins family, plays an important biological role in the occurrence and development of melanoma. EZH2 germline genetic polymorphisms have not been yet evaluated in melanoma predisposition. Three hundred thirty sporadic Italian melanoma patients and 333 healthy volunteers were genotyped to analyse...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line, Tumor
Share to Enhancer of Zeste Homolog 2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation

Share to Haplotypes

Share to HEK293 Cells

Share to Melanoma

Share to Promoter Regions, Genetic

Share to Skin Neoplasms

Source

Identifiers

PMID: 32748461
DOI: 10.1111/exd.14163

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Enhancer of zeste 2 polycomb repressive complex 2 subunit polymorphisms in melanoma skin cancer risk.PMID 32748461Read ↗

EZH2 in Acral Lentiginous Melanoma: Molecular, Epigenetic, and Therapeutic Perspectives.Semantic proximity Read ↗

The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors.Semantic proximity Read ↗

EZH2 Abundance Regulated by UHRF1/UBE2L6/UBR4 Ubiquitin System is the Potential Therapeutic Target to Trigger Pigmented Phenotype in MelanomaSemantic proximity Read ↗

Somatic Copy Number Amplification and Hyperactivating Somatic Mutations of EZH2 Correlate With DNA Methylation and Drive Epigenetic Silencing of Genes Involved in Tumor Suppression and Immune Responses in Melanoma.Semantic proximity Read ↗

Stat3 co-operates with mutant <i>Ezh2</i> <sup>Y641F</sup> to regulate gene expression and limit the anti-tumor immune response in melanomaSemantic proximity Read ↗

Functional annotation and investigation of the 10q24.33 melanoma risk locus identifies a common variant that influences transcriptional regulation of OBFC1.Semantic proximity Read ↗

Epigenetic Modifications in Cutaneous Malignant MelanomaSemantic proximity Read ↗

Ezh2Y641F mutations co-operate with Stat3 to regulate MHC class I antigen processing and alter the tumor immune response in melanoma.Semantic proximity Read ↗

Variants of the xeroderma pigmentosum variant gene (POLH) are associated with melanoma risk.Semantic proximity Read ↗

Effects of EZH2 polymorphisms on susceptibility to and pathological development of hepatocellular carcinoma.Semantic proximity Read ↗

Polycomb subunits Ezh1 and Ezh2 regulate the Merkel cell differentiation program in skin stem cellsSemantic proximity Read ↗

Meta-analysis of Genetic polymorphism of Enhancer of Zeste Homolog2 gene in cancer susceptibility.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.